Ptc Therapeutics (PTCT) Asset Utilization Ratio (2013 - 2026)

Ptc Therapeutics' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.29 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 60.58% year-over-year to 0.29 in Q1 2026; TTM through Mar 2026 was 0.29, a 60.58% decrease from a year earlier, with the FY2025 full-year figure at 0.75, up 67.78% from the prior year.
• Asset Utilization Ratio fell to 0.29 in Q1 2026 per PTCT's latest filing, from 0.62 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.73 in Q1 2025 and bottomed at 0.29 in Q1 2026.
• The 5-year median for Asset Utilization Ratio is 0.46 (2023), against an average of 0.49.
• Across the five-year window, Asset Utilization Ratio jumped 78.63% in 2025 and slumped 60.58% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.43 in 2022, then surged by 39.58% to 0.59 in 2023, then slumped by 41.18% to 0.35 in 2024, then soared by 78.63% to 0.62 in 2025, then sank by 54.08% to 0.29 in 2026.
• Per Business Quant, the three latest PTCT Asset Utilization Ratio figures stand at 0.29 (Q1 2026), 0.62 (Q4 2025), and 0.67 (Q3 2025).